Figure 1.
Proposed algorithm for first-line treatment choice in untreated BRAF-V600 mutant metastatic melanoma patients.
BRAFi, BRAF inhibitor; LDH, serum lactate dehydrogenase; MEKi, MEK inhibitor; SLD, sum of lesion diameters.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.